Get started
Author

Jan Kořen

Observed names: J Koren, J Kořen, J. Koren, J. Kořen, Jan Koren
Institution: Charles University
ORCID: 0000-0002-7884-7821
Observed ORCID: 0000-0002-7884-7821
OpenAlex ID: A5007471107
Morphologic Diversity of Malignant Neoplasms Arising in Preexisting Spiradenoma, Cylindroma, and Spiradenocylindroma Based on the Study of 24 Cases, Sporadic or Occurring in the Setting of Brooke-Spiegler Syndrome
2009 · Dmitry V. Kazakov, Bernhard Zelger, et al. · The American Journal of Surgical Pathology · 156
Mullerianosis of the urinary bladder: report of a case with suggested metaplastic origin
2006 · Jan Koren, Jana Mensikova, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 53
Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi‐agent chemotherapy
2018 · Jan Walewski, Andrzej Hellmann, et al. · British Journal of Haematology · 27
Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study
2021 · Martin Hutchings, John Radford, et al. · Hematological Oncology · 20
PDF
Outcome of elderly patients with classical Hodgkin’s lymphoma
2020 · A. Sykorova, H. Mocikova, et al. · Leukemia Research · 14
Mitotically active deep juvenile xanthogranuloma
2009 · Jan Koren, Ludovit Matecek, et al. · Annals of Diagnostic Pathology · 14
Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma?
2015 · Heidi Mocikova, Robert Pytlik, et al. · Acta Haematologica · 5
PDF
Proton beam therapy for mediastinal Hodgkin lymphoma: A prospective study of clinical efficacy and safety
2025 · Kateřina Dědečková, Michal Andrlik, et al. · Radiotherapy and Oncology · 4
Retrospective analysis of the results of high-dose chemotherapy with the support of autologous blood stem cells in patients with multiple myeloma. The experience of a single centre.
2010 · J Kořen, I Spička, et al. · PubMed · 4
[Adenomatoid tumor of the right adrenal gland: a case report].
2005 · J Koren, P Cunderlík · PubMed · 3
The journey of patients with diffuse large B-cell lymphoma: from symptoms to diagnosis
2025 · Prokop Vodicka, Michal Masar, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2
PDF
P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic.
2022 · Jozef Michalka, Jana Marková, et al. · HemaSphere · 2
Optimizing risk stratification in patients aged 80+ years with large B-cell lymphoma: Comparison of prognostic indices in three pooled international cohorts
2025 · Prokop Vodicka, Yucai Wang, et al. · Blood · 1
Risk of Central Nervous System Vs. Systemic Relapse in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: What Should We Focus on?
2023 · Magdalena Klanova, Samuel Hricko, et al. · Blood · 1
DLBCL Patients' Journey: From Symptoms to Diagnosis
2023 · Prokop Vodicka, Michal Masar, et al. · Blood · 1
Multicenter Retrospective Analysis of Risk Factors for Mortality of Covid‐19 Infection in Patients With Lymphoma
2021 · J. Kořen, K. Steinerová, et al. · Hematological Oncology · 1
PDF
Solid Epithelioid Hemangioma of the Heart: Report of a Case with Unusual Thread-Like Bridging Strands
2015 · Jan Koren, Michal Zamecnik · Journal of Interdisciplinary Histopathology · 1
[The outcome of whole-body FDG-PET examination predicts the future of patients with diffuse large-cell lymphoma in the use of both intermediary staging and at the end of standard chemotherapy].
2007 · M Trnený, O Belohlávek, et al. · PubMed · 1
[Columnar cell carcinoma of the thyroid gland--case report].
2004 · J Koren, Z Opravil, et al. · PubMed · 1
[Pseudomalignant changes in benign phyllodes breast tumor].
2002 · J Koren · PubMed · 1
Comorbidity burden and prognosis in patients aged 80+ years with large B-cell lymphoma
2026 · Prokop Vodička, Michal Masár, et al. · Clinical Lymphoma Myeloma & Leukemia
Survival Improvement of DLBCL Patients Treated with Third Line and Beyond in the Recent Era in the Czech Republic
2026 · Prokop Vodicka, Andrea Janikova, et al. · Blood Advances
Predictive performance of the LEO comorbidity index in patients aged 80+ years with large B-cell lymphoma
2025 · Prokop Vodicka, Michal Masar, et al. · Blood
PDF
Comparable PFS in isolated parenchymal cns vs systemic relapse of DLBCL: Results from a large real-world cohort
2025 · Michal Masar, Prokop Vodicka, et al. · Blood
PDF
Treatment patterns in patients aged 80+ years with LBCL: Propensity score analysis reveals comparable outcomes between R-CHOP and R-mini-CHOP
2025 · Prokop Vodicka, Patrick Reagan, et al. · Blood
PDF
Works count: 40
Citation count: 312
H-index: 6
I10-index: 6
Year
Topic
Type